Trump's 200% tariff threat: Which Indian pharma companies are most exposed?

Brokerage firm JM Financial noted that the announcement is negative for Indian companies like Aurobindo Pharma, Dr Reddys Laboratories, Lupin, Sun Pharmaceutical Industries, Zydus Lifesciences, etc.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *